Literature DB >> 28329333

Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter.

Claire Dumont1, Elena Galli1,2,3, Emmanuel Oger4, Maxime Fournet1, Erwan Flecher2,3,5, Christophe Leclercq1,2,3, Jean-Philippe Verhoye2,3,5, Erwan Donal1,2,3.   

Abstract

Aims: Secondary tricuspid regurgitation (STR) is commonly found in patients with aortic stenosis and is associated with increased morbidity. The study sought to evaluate the prevalence of pre-operative STR and its progression after surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI). Also, it sought to analyse the predictors of post-operative changes in STR. Methods and results: We prospectively evaluated 116 patients (aged 75.1 ± 9.8 years, predominantly male) who undergo SAVR or TAVI for severe aortic stenosis (AS) from September 2013 to April 2015. Patients with associated valve disease requiring intervention, significant coronary artery disease or left ventricular ejection fraction (LVEF) <50% were excluded. Clinical and echocardiographic data, including TR grade and right ventricular (RV) size and function, were assessed at baseline and at the 1-year follow-up. At baseline, significant TR was documented in 13 patients (11.1%) and non-significant TR was documented in 103 patients (88.9%). Atrial fibrillation (AF) was more prevalent in patients with a tricuspid annulus diameter ≥40 mm (P < 0.0051). At the 1-year follow-up, the TR grade had improved in 17 patients (14.7%), was unchanged in 68 patients (58.6%) and had worsened in 31 patients (26.7%). Moderate to severe TR was found in 30 patients (25.8%). Tricuspid annulus diameter >40 mm was the only echocardiographic predictor of significant postoperative TR (relative risk (RR) = 2.12 [1.26-3.54], P = 0.004). Right heart function and size were not independent predictors.
Conclusion: Significant TR was present pre-operatively in 11.1% of patients. Post-operative progression was observed in 26.7% of patients. Only tricuspid annulus size >40 mm was an independent echocardiographic predictor of moderate to severe TR at the 1-year follow-up. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2018        PMID: 28329333     DOI: 10.1093/ehjci/jex031

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  6 in total

Review 1.  Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure.

Authors:  Chirag Bavishi; Dhaval Kolte; Paul C Gordon; J Dawn Abbott
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 2.  Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.

Authors:  Lluis Asmarats; Maurizio Taramasso; Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

Review 3.  The Pivotal Role of Imaging in TAVR Procedures.

Authors:  Caroline Bleakley; Mark J Monaghan
Journal:  Curr Cardiol Rep       Date:  2018-02-12       Impact factor: 2.931

Review 4.  Functional Tricuspid Regurgitation: Behind the Scenes of a Long-Time Neglected Disease.

Authors:  Mattia Vinciguerra; Marta Sitges; Jose Luis Pomar; Silvia Romiti; Blanca Domenech-Ximenos; Mizar D'Abramo; Eleonora Wretschko; Fabio Miraldi; Ernesto Greco
Journal:  Front Cardiovasc Med       Date:  2022-02-21

5.  Surgical management of tricuspid regurgitation: a new algorithm to minimise recurrent tricuspid regurgitation.

Authors:  Diego Rodriguez Torres; Lucía Torres Quintero; Diego Segura Rodríguez; Jose Manuel Garrido Jimenez; Maria Esteban Molina; Francisco Gomera Martínez; Eduardo Moreno Escobar; Rocio Garcia Orta
Journal:  Open Heart       Date:  2022-07

6.  Managing tricuspid valve pathology in multiple valvular heart disease.

Authors:  Denny Suwanto; Ivana Purnama Dewi; Mohammad Budiarto
Journal:  Ann Med Surg (Lond)       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.